Pradžia › Geografinė atrofija › Masčusetsas
Geografinė atrofija klinikiniai tyrimai Masčusetsas
7 tyrimai dėl Geografinė atrofija ieško dalyvių vietose Masčusetsas.
Miestai Masčusetsas
Oficialus tyrimo tekstas (anglų kalba)
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
- Ophthalmic Consultants of Boston, Boston
Renkami dalyviai2/3 fazė
Amžius 60 ir vyresni · Visoms lytims · Atnaujinta 2026-09-30 · NCT06635148A Study in Adults With Geographic Atrophy
- Ophthalmic Consultants of Boston, Waltham
Renkami dalyviai2 fazė
Amžius 60 ir vyresni · Visoms lytims · Atnaujinta 2026-09-21 · NCT07606365A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
- Massachusetts Eye And Ear Infirmary, Boston
- Opthalmic Consultants of Boston, Boston
- New England Retina Consultants, PC, Springfield
- ir dar 2
Renkami dalyviai3 fazė
Amžius nuo 50 iki 85 · Visoms lytims · Atnaujinta 2026-09-18 · NCT06541704Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
- Retina Research Institute at New England Retina Consultants, Springfield
Renkami dalyviai2 fazė
Amžius 55 ir vyresni · Visoms lytims · Atnaujinta 2026-09-10 · NCT06659445A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
- Ophthalmic Consultants of Boston, Boston
Renkami dalyviai1 fazė
Amžius 50 ir vyresni · Visoms lytims · Atnaujinta 2026-09-03 · NCT03178149Intravitreal (IVT) Pozelimab for Geographic Atrophy (GA) in Adult Participants
- Ophthalmic Consultants of Boston, East Weymouth
Renkami dalyviai1 fazė
Amžius 50 ir vyresni · Visoms lytims · Atnaujinta 2026-08-05 · NCT07230834Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD
- Tallman Eye Associates, Lawrence
Renkami dalyviai
Amžius 65 ir vyresni · Visoms lytims · Atnaujinta 2024-12-03 · NCT05438732Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.